Owner only: item control page
Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124]
Seitz, Stephan, Buchholz, Stefan, Schally, Andrew V.
, Jayakumar, Arumugam R., Weber, Florian, Papadia, Andrea , Rick, Ferenc G. , Szalontay, Luca, Treszl, Andrea, Köster, Frank, Ortmann, Olaf and Hohla, Florian
(2013)
Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124].
Anti-Cancer Drugs 24 (2), pp. 150-157.
Date of publication of this fulltext: 19 Dec 2024 08:44
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Anti-Cancer Drugs | ||||
| Publisher: | LIPPINCOTT WILLIAMS & WILKINS | ||||
|---|---|---|---|---|---|
| Place of Publication: | PHILADELPHIA | ||||
| Volume: | 24 | ||||
| Number of Issue or Book Chapter: | 2 | ||||
| Page Range: | pp. 150-157 | ||||
| Date | 2013 | ||||
| Institutions | Medicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Geburtshilfe) Medicine > Lehrstuhl für Pathologie | ||||
| Identification Number |
| ||||
| Keywords | HORMONE-RELEASING HORMONE; 500-1000 TIMES; IN-VITRO; DOXORUBICIN; INTERNALIZATION; THERAPY; GROWTH; 2-PYRROLINODOXORUBICIN; ENDOMETRIAL; INHIBITION; AN-162; breast cancer; doxorubicin; internalization; somatostatin; targeted therapy; triple-negative breast cancer | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 62885 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric